Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications-Reference-Cited by-同舟云学术

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications

Published:2010-07-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Stowe Rebecca¹,Ives Natalie¹,Clarke Carl E²,Deane Katherine³,van Hilten ⁴,Wheatley Keith⁵,Gray Richard⁶,Handley Kelly¹,Furmston Alex¹

Affiliation:

1. University of Birmingham; Birmingham Clinical Trials Unit; Edgbaston Birmingham UK B15 2TT

2. College of Medicine and DentalSciences; School of Clinical and Experimental Medicine; University of Birmingham Edgbaston Birmingham West Midlands UK B18 7QH

3. University of East Anglia; Edith Cavell Building; Norwich UK NR4 7TJ

4. Leiden University of Medical Center; Department of Neurology; Albinusdreef 2 Leiden Netherlands 2333 ZA

5. University of Birmingham; Cancer Research UK Clinical Trials Unit, School of Cancer Sciences; Edgbaston Birmingham UK B15 2TT

6. The University of Birmingham; Clinical Trials Unit; Robert Aitken Institute for Clincial Research College of Medical Sciences Birmingham UK B15 2TT

Publisher

Wiley

Subject

Pharmacology (medical)

Reference170 articles.

1. Brooks DJ Kuoppamaki M Vahteristo M Entacapone decreases axial symptoms and tremor in levodopa-treated Parkinson's disease patients experiencing wearing-off symptoms Movement Disorders 2005 S120 (P405)

2. Deuschl G Poewe W Poepping M and the Celomen Study Group Efficacy and safety of entacapone as an adjunct to levodopa treatment in Parkinson's disease (PD): Experience from the Austrian-German six months study Parkinsonism and Related Disorders 1999 S75 (P-TU-100)

3. Poewe W Deuschl G and Celomen Study Group The effect of entacapone in patients with Parkinson's disease (PD): An Austrian-German long-term multicentre study (Celomen Study) European Journal of Neurology 1999 78 (P194)

4. Poewe W Deuschl G Kultalahti E-R Haapaniemi H Leinonen M Reinikainen K Gordin A The efficacy and tolerability of entacapone used in combination with controlled release levodopa preparations in patients with Parkinson's disease Parkinsonism and Related Disorders 2001 S66 (P-TU-221)

5. Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: A 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen Study);Poewe;Acta Neurologica Scandinavica,2002

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

2. Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies;Journal of Neural Transmission;2024-07-15

3. Comparison of the effectiveness, safety, and costs of anti‐Parkinson drugs: A multiple‐center retrospective study;CNS Neuroscience & Therapeutics;2023-11-20

4. Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease;Expert Opinion on Drug Safety;2023-07-03

5. Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis;European Journal of Neurology;2023-05-25